BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
5 hedge funds and large institutions have $4.64M invested in BriaCell Therapeutics Corp Warrant in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
7% more capital invested
Capital invested by funds: $4.31M → $4.64M (+$323K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
5.45% less ownership
Funds ownership: 12.01% → 6.56% (-5.4%)
38% less funds holding
Funds holding: 8 → 5 (-3)
62% less call options, than puts
Call options by funds: $2.15M | Put options by funds: $5.65M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$650K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$130K |
| 2 |
Morgan Stanley
New York
|
-$51K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| 4 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$6.13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
M
1
Murchinson
Toronto,
Ontario, Canada
| $1.78M | +$650K | +137,775 | +54% |
|
|
AC
2
Armistice Capital
New York
| $1.76M | – | – | – |
|
|
KJHP
3
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| $541K | -$6.13K | -1,299 | -1% |
|
|
RAM
4
Redmond Asset Management
Henrico,
Virginia
| $341K | – | – | – |
|
|
ZCA
5
Zeke Capital Advisors
Berwyn,
Pennsylvania
| $211K | – | – | – |
|
|
WAM
6
Warberg Asset Management
Winnetka,
Illinois
| – | -$130K | -27,000 | Closed |
|
|
7
Morgan Stanley
New York
| – | -$51K | -10,752 | Closed |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$10K | -2,082 | Closed |
|
BCTXW Hedge Fund Activity: Q4 2021 in Review
5 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q4 2021, worth a combined $4.64M — up 7.5% from $4.31M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BCTXW and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Murchinson, adding an estimated $650K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $130K sold.
- 5 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q4 2021, down from 8 in Q3 2021.
- Funds reported $4.64M of BriaCell Therapeutics Corp Warrant stock for Q4 2021, up 7.5% quarter-over-quarter.
- 0 funds opened new BriaCell Therapeutics Corp Warrant positions in Q4 2021 and 3 closed out, a net change of -3 holders.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q4 2021 was Murchinson, an estimated $650K added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q4 2021 was Warberg Asset Management, an estimated $130K sold.
Based on aggregated 13F filings for Q4 2021.